Follow
Kow Essuman
Kow Essuman
Massachusetts General Hospital
Verified email at mgh.harvard.edu
Title
Cited by
Cited by
Year
The SARM1 toll/interleukin-1 receptor domain possesses intrinsic NAD+ cleavage activity that promotes pathological axonal degeneration
K Essuman, DW Summers, Y Sasaki, X Mao, A DiAntonio, J Milbrandt
Neuron 93 (6), 1334-1343. e5, 2017
5312017
TIR domains of plant immune receptors are NAD+-cleaving enzymes that promote cell death
L Wan, K Essuman, RG Anderson, Y Sasaki, F Monteiro, EH Chung, ...
Science 365 (6455), 799-803, 2019
3832019
TIR domain proteins are an ancient family of NAD+-consuming enzymes
K Essuman, DW Summers, Y Sasaki, X Mao, AKY Yim, A DiAntonio, ...
Current Biology 28 (3), 421-430. e4, 2018
2152018
Dynamic recruitment of microRNAs to their mRNA targets in the regenerating liver
J Schug, LB McKenna, G Walton, N Hand, S Mukherjee, K Essuman, ...
BMC genomics 14, 1-11, 2013
762013
Shared TIR enzymatic functions regulate cell death and immunity across the tree of life
K Essuman, J Milbrandt, JL Dangl, MT Nishimura
Science 377 (6605), eabo0001, 2022
622022
Distinct developmental and degenerative functions of SARM1 require NAD+ hydrolase activity
EJ Brace, K Essuman, X Mao, J Palucki, Y Sasaki, J Milbrandt, ...
PLoS genetics 18 (6), e1010246, 2022
82022
The enzymatic function of the TIR domain: from axon degeneration to innate immunity
KA Essuman
Washington University in St. Louis, 2020
12020
Inhibitors of SARM1 NADase activity and uses thereof
J Milbrandt, K Essuman, Y Sasaki, A DiAntonio, MAO Xianrong, R Devraj, ...
US Patent 11,903,935, 2024
2024
The structure of NAD+ consuming protein Acinetobacter baumannii TIR domain shows unique kinetics and conformations
E Klontz, JO Obi, Y Wang, G Glendening, J Carr, C Tsibouris, S Buddula, ...
Journal of Biological Chemistry 299 (11), 2023
2023
IDENTIFICATION OF INHIBITORS OF TCPC AND TIR NADase ACTIVITY
JD Milbrandt, A DiAntonio, K Essuman, MAO Xianrong, Y Sasaki, ...
US Patent App. 18/059,838, 2023
2023
Inhibitors of SARM1 NADase activity and uses thereof
J Milbrandt, K Essuman, Y Sasaki, A DiAntonio, MAO Xianrong, R Devraj, ...
US Patent 11,253,503, 2022
2022
IDENTIFICATION OF INHIBITORS OF TCPC AND TIR NADase ACTIVITY
JD Milbrandt, A DiAntonio, K Essuman, MAO Xianrong, Y Sasaki, ...
US Patent App. 16/651,196, 2020
2020
Redefining the TIR domain: From Axon Degeneration to Innate Immunity and Beyond
K Essuman, L Wan, DW Summers, RG Anderson, Y Sasaki, X Mao, ...
The Journal of Immunology 202 (1_Supplement), 64.1-64.1, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–13